US Stock MarketDetailed Quotes

PEARQ Pear Therapeutics

Watchlist

0.000001
0.0000000.00%

15min DelayTrading May 24 16:00 ET

142.74Market Cap0.00P/E (TTM)

Pear Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

Total revenue

201.66%12.69M

94.32%2.57M

211.44%4.08M

174.52%3.3M

631.12%2.75M

-55.16%4.21M

3,782.35%1.32M

1,625.00%1.31M

1.2M

376K

Operating revenue

201.66%12.69M

94.32%2.57M

211.44%4.08M

174.52%3.3M

631.12%2.75M

-55.16%4.21M

3,782.35%1.32M

1,625.00%1.31M

--1.2M

--376K

Cost of revenue

56.35%8.18M

5.89%1.75M

20.52%2.56M

230.26%2.4M

100.68%1.48M

204.60%5.23M

337.14%1.65M

396.49%2.12M

727K

738K

Gross profit

540.20%4.51M

350.00%820K

288.88%1.53M

89.03%896K

450.28%1.27M

-113.37%-1.03M

4.37%-328K

-130.48%-809K

474K

-362K

Operating expense

22.17%127.86M

-11.58%29.98M

2.23%28.16M

50.36%33.72M

73.21%36.01M

24.14%104.66M

17.33%33.91M

52.64%27.54M

22.42M

20.79M

Selling and administrative expenses

17.65%79.55M

-17.28%18.04M

-1.11%17.77M

44.37%21M

71.03%22.75M

20.26%67.62M

-3.42%21.81M

53.58%17.97M

--14.55M

--13.3M

Research and development costs

30.43%48.31M

-1.30%11.94M

8.50%10.39M

61.43%12.72M

77.09%13.26M

31.89%37.04M

91.48%12.1M

50.90%9.58M

--7.88M

--7.49M

Operating profit

-16.71%-123.35M

14.82%-29.16M

6.07%-26.63M

-49.53%-32.82M

-64.25%-34.74M

-37.89%-105.69M

-17.07%-34.23M

-54.12%-28.35M

-21.95M

-21.15M

Net non-operating interest income expense

6.08%-3.89M

-78.26%-1.89M

37.91%-647K

66.31%-343K

0.97%-1.02M

-134.52%-4.14M

-25.80%-1.06M

-0.10%-1.04M

-1.02M

-1.03M

Total other finance cost

-6.08%3.89M

78.26%1.89M

-37.91%647K

-66.31%343K

-0.97%1.02M

134.52%4.14M

25.80%1.06M

0.10%1.04M

--1.02M

--1.03M

Other net income (expense)

15.81%51.75M

-91.35%4.68M

-80.94%-3.45M

837.96%38.63M

636.91%11.9M

340.10%44.69M

407.67%54.04M

-6,468.97%-1.91M

-5.23M

-2.22M

Gain on sale of security

2,251.68%6.41M

-95.76%297K

67.56%-618K

280.78%9.46M

-1,574.23%-2.73M

62.52%-298K

1,037.62%7M

-6,703.57%-1.91M

---5.23M

---163K

Special income (charges)

-3.61%45.34M

-90.69%4.38M

---2.83M

--29.16M

--14.63M

4,813.23%47.04M

4,703,700.00%47.04M

--0

-Less：Restructuring and merger&acquisition

3.61%-45.34M

90.69%-4.38M

--2.83M

---29.16M

---14.63M

---47.04M

--0

Other non- operating income (expenses)

----

87.79%-2.05M

--0

----

---2.05M

Income before tax

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

32.86%-65.14M

139.35%18.75M

-60.79%-31.3M

-28.2M

-24.39M

Income tax

Net income

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

32.86%-65.14M

139.35%18.75M

-60.79%-31.3M

-28.2M

-24.39M

Net income continuous Operations

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

32.86%-65.14M

139.35%18.75M

-60.79%-31.3M

---28.2M

---24.39M

Minority interest income

Net income attributable to the parent company

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

32.86%-65.14M

139.35%18.75M

-60.79%-31.3M

-28.2M

-24.39M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-15.89%-75.49M

-240.65%-26.37M

1.84%-30.72M

119.37%5.46M

2.19%-23.86M

39.73%-65.14M

131.94%18.75M

-60.79%-31.3M

-28.2M

-24.39M

Basic earnings per share

5.26%-0.54

-218.75%-0.19

3.14%-0.22

119.55%0.04

3.96%-0.17

27.32%-0.57

137.56%0.16

-60.79%-0.2271

-0.2047

-0.177

Diluted earnings per share

5.26%-0.54

-246.15%-0.19

3.14%-0.22

119.55%0.04

3.96%-0.17

27.32%-0.57

130.52%0.13

-60.79%-0.2271

-0.2047

-0.177

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021
Total revenue	201.66%12.69M	94.32%2.57M	211.44%4.08M	174.52%3.3M	631.12%2.75M	-55.16%4.21M	3,782.35%1.32M	1,625.00%1.31M	1.2M	376K
Operating revenue	201.66%12.69M	94.32%2.57M	211.44%4.08M	174.52%3.3M	631.12%2.75M	-55.16%4.21M	3,782.35%1.32M	1,625.00%1.31M	--1.2M	--376K
Cost of revenue	56.35%8.18M	5.89%1.75M	20.52%2.56M	230.26%2.4M	100.68%1.48M	204.60%5.23M	337.14%1.65M	396.49%2.12M	727K	738K
Gross profit	540.20%4.51M	350.00%820K	288.88%1.53M	89.03%896K	450.28%1.27M	-113.37%-1.03M	4.37%-328K	-130.48%-809K	474K	-362K
Operating expense	22.17%127.86M	-11.58%29.98M	2.23%28.16M	50.36%33.72M	73.21%36.01M	24.14%104.66M	17.33%33.91M	52.64%27.54M	22.42M	20.79M
Selling and administrative expenses	17.65%79.55M	-17.28%18.04M	-1.11%17.77M	44.37%21M	71.03%22.75M	20.26%67.62M	-3.42%21.81M	53.58%17.97M	--14.55M	--13.3M
Research and development costs	30.43%48.31M	-1.30%11.94M	8.50%10.39M	61.43%12.72M	77.09%13.26M	31.89%37.04M	91.48%12.1M	50.90%9.58M	--7.88M	--7.49M
Operating profit	-16.71%-123.35M	14.82%-29.16M	6.07%-26.63M	-49.53%-32.82M	-64.25%-34.74M	-37.89%-105.69M	-17.07%-34.23M	-54.12%-28.35M	-21.95M	-21.15M
Net non-operating interest income expense	6.08%-3.89M	-78.26%-1.89M	37.91%-647K	66.31%-343K	0.97%-1.02M	-134.52%-4.14M	-25.80%-1.06M	-0.10%-1.04M	-1.02M	-1.03M
Total other finance cost	-6.08%3.89M	78.26%1.89M	-37.91%647K	-66.31%343K	-0.97%1.02M	134.52%4.14M	25.80%1.06M	0.10%1.04M	--1.02M	--1.03M
Other net income (expense)	15.81%51.75M	-91.35%4.68M	-80.94%-3.45M	837.96%38.63M	636.91%11.9M	340.10%44.69M	407.67%54.04M	-6,468.97%-1.91M	-5.23M	-2.22M
Gain on sale of security	2,251.68%6.41M	-95.76%297K	67.56%-618K	280.78%9.46M	-1,574.23%-2.73M	62.52%-298K	1,037.62%7M	-6,703.57%-1.91M	---5.23M	---163K
Special income (charges)	-3.61%45.34M	-90.69%4.38M	---2.83M	--29.16M	--14.63M	4,813.23%47.04M	4,703,700.00%47.04M	--0	--0	--0
-Less：Restructuring and merger&acquisition	3.61%-45.34M	90.69%-4.38M	--2.83M	---29.16M	---14.63M	---47.04M	---47.04M	--0	--0	--0
Other non- operating income (expenses)	----	----	----	----	----	87.79%-2.05M	--0	----	----	---2.05M
Income before tax	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	32.86%-65.14M	139.35%18.75M	-60.79%-31.3M	-28.2M	-24.39M
Income tax
Net income	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	32.86%-65.14M	139.35%18.75M	-60.79%-31.3M	-28.2M	-24.39M
Net income continuous Operations	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	32.86%-65.14M	139.35%18.75M	-60.79%-31.3M	---28.2M	---24.39M
Minority interest income
Net income attributable to the parent company	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	32.86%-65.14M	139.35%18.75M	-60.79%-31.3M	-28.2M	-24.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-15.89%-75.49M	-240.65%-26.37M	1.84%-30.72M	119.37%5.46M	2.19%-23.86M	39.73%-65.14M	131.94%18.75M	-60.79%-31.3M	-28.2M	-24.39M
Basic earnings per share	5.26%-0.54	-218.75%-0.19	3.14%-0.22	119.55%0.04	3.96%-0.17	27.32%-0.57	137.56%0.16	-60.79%-0.2271	-0.2047	-0.177
Diluted earnings per share	5.26%-0.54	-246.15%-0.19	3.14%-0.22	119.55%0.04	3.96%-0.17	27.32%-0.57	130.52%0.13	-60.79%-0.2271	-0.2047	-0.177
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data